Cargando…
Recent Update in Pharmacological Agents for Optic Pathway Glioma
Optic pathway gliomas (OPGs) are insidious, debilitating low-grade tumors. They can affect the optic nerve, optic chiasm, and optic tracts and can be sporadic or associated with neurofibromatosis type 1 (NF1). The location of OPGs within the optic pathway typically precludes complete resection or op...
Autor principal: | Park, Meerim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Brain Tumor Society; The Korean Society for Neuro-Oncology; The Korean Society for Pediatric Neuro-Oncology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098979/ https://www.ncbi.nlm.nih.gov/pubmed/35545829 http://dx.doi.org/10.14791/btrt.2022.0006 |
Ejemplares similares
-
Recent Updates on Radiation Therapy for Pediatric Optic Pathway Glioma
por: Kim, Nalee, et al.
Publicado: (2022) -
Recent Updates in Pharmacological Properties of Chitooligosaccharides
por: Marmouzi, Ilias, et al.
Publicado: (2019) -
Pediatric Glioma at the Optic Pathway and Thalamus
por: Park, Eun Suk, et al.
Publicado: (2018) -
Bevacizumab as Single Agent in Children and Teenagers with Optic Pathway Glioma
por: Calò, Pierluigi, et al.
Publicado: (2023) -
Updated Insights on EGFR Signaling Pathways in Glioma
por: Oprita, Alexandru, et al.
Publicado: (2021)